High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women.
about
Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationNOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.Microextraction by Packed Sorbent (MEPS) and Solid-Phase Microextraction (SPME) as Sample Preparation Procedures for the Metabolomic Profiling of Urine.Chronic stress increases vulnerability to diet-related abdominal fat, oxidative stress, and metabolic riskPooling designs for outcomes under a Gaussian random effects model.Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples.Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic ratsOxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients.Investigating endothelial activation and oxidative stress in relation to glycaemic control in a multiethnic population.Oxidative stress in Complex Regional Pain Syndrome (CRPS): no systemically elevated levels of malondialdehyde, F2-isoprostanes and 8OHdG in a selected sample of patients.Oxidative stress and response in relation to coronary artery disease in type 1 diabetes.Multimarker approach for identifying and documenting mitigation of cardiovascular risk.Sleep duration, nightshift work, and the timing of meals and urinary levels of 8-isoprostane and 6-sulfatoxymelatonin in Japanese women.F2-Isoprostanes Reflect Oxidative Stress Correlated With Lean Mass and Bone Density but Not Insulin Resistance.
P2860
Q26864770-E8BC2A91-E1EB-42D4-8BC6-D10D243E2248Q33583595-81D4414A-E7B0-40E8-B6FA-0C858E340FC0Q33601018-B074D328-E56B-4A44-A49A-92361C03FCA2Q33923329-F31AA29A-5D48-45FC-9606-585D6183C1A5Q34155857-D470D045-55E9-457B-8364-82975E0614A2Q34436623-6A10C209-5E46-4236-9E7C-3B3A7A487F06Q34489018-5B3CE399-9258-4BCE-938E-B5BB241ABC8EQ35998367-0F3745AC-0C9A-49EF-BBC1-C29F5ED3ACC0Q36469048-10FB2FC0-CE0C-40CF-8C38-934D1ECEE20AQ36820521-B0C6BAA6-7069-4D6A-8C57-C4BBC240E4C2Q37278164-A7D11363-17A6-407E-8AAE-E58E68079214Q38120089-535BC940-F78A-4864-BC44-34D70DEC1F9EQ47682829-D94D652C-0BA7-47D7-8336-0D598A1A4117Q51776573-C9491275-7DCD-46A3-B930-6C43D680635D
P2860
High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
High levels of urinary F2-isop ...... ality in postmenopausal women.
@en
High levels of urinary F2-isop ...... ality in postmenopausal women.
@nl
type
label
High levels of urinary F2-isop ...... ality in postmenopausal women.
@en
High levels of urinary F2-isop ...... ality in postmenopausal women.
@nl
prefLabel
High levels of urinary F2-isop ...... ality in postmenopausal women.
@en
High levels of urinary F2-isop ...... ality in postmenopausal women.
@nl
P2093
P1476
High levels of urinary F2-isop ...... ality in postmenopausal women.
@en
P2093
Hieronymus A M Voorbij
Mark Roest
Peter G Scheffer
Petra H M Peeters
Tom Teerlink
P304
P356
10.1016/J.JACL.2008.06.004
P407
P577
2008-06-13T00:00:00Z